We are live on
!
Find out more
PDLI
PDL BioPharma, Inc.
PDLI
PDLI
Delisted
PDLI was delisted on the 30th of December, 2020.
190 hedge funds and large institutions have $276M invested in PDL BioPharma, Inc. in 2016 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 56 increasing their positions, 66 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
511% more call options, than puts
Call options by funds: $1.39M | Put options by funds: $227K
4% less funds holding
Funds holding: 197 → 190 (-7)
15% less repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 66
16% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 32
36% less capital invested
Capital invested by funds: $434M → $276M (-$158M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
190
Holders Change
-7
Holders Change %
-3.55%
% of All Funds
4.75%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
27
Increased
56
Reduced
66
Closed
32
Calls
$1.39M
Puts
$227K
Net Calls
+$1.16M
Net Calls Change
+$1.21M
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$8.25M |
| 2 |
Morgan Stanley
New York
|
+$4.13M |
| 3 |
JP Morgan Chase
New York
|
+$3.68M |
| 4 |
ACPU
Arrowgrass Capital Partners (US)
Dover,
Delaware
|
+$2.85M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$2.72M |
